Click for best price
Nasopharyngeal Cancer Market Size, Share 2023
Nasopharyngeal is a type of cancer which takes place in head or neck. It happens in nasopharynx, which is a upper part of the of the throat behind the nose. It is also called nasopharyngeal carcinoma (NPC). It has also been linked with Epstein-Barr virus.
This report aims to provide a comprehensive presentation of the global market for Nasopharyngeal Cancer, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nasopharyngeal Cancer. This report contains market size and forecasts of Nasopharyngeal Cancer in global, including the following market information:
Global Nasopharyngeal Cancer Market Revenue, 2018-2023, 2024-2035, ($ millions)
Global top five companies in 2022 (%)
The global Nasopharyngeal Cancer market was valued at US$ million in 2022 and is projected to reach US$ million by 2035, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Increasing geriatric population, rise in consumption of tobacco, increasing health awareness, changing lifestyle, are key driving factors for nasopharyngeal cancer treatment market.
We surveyed the Nasopharyngeal Cancer companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nasopharyngeal Cancer Market, by Type, 2018-2023, 2024-2035 ($ millions)
Global Nasopharyngeal Cancer Market Segment Percentages, by Type, 2022 (%)
Surgery
Radiation
Chemotherapy
Global Nasopharyngeal Cancer Market, by Application, 2018-2023, 2024-2035 ($ millions)
Global Nasopharyngeal Cancer Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Cancer Treatment and Rehabilitation Centers
Global Nasopharyngeal Cancer Market, By Region and Country, 2018-2023, 2024-2035 ($ Millions)
Global Nasopharyngeal Cancer Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Nasopharyngeal Cancer revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Nasopharyngeal Cancer revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Sanofi
Merck
Cyclacel Pharmaceuticals
Celgene
BioDiem
Outline of Major Chapters:
Chapter 1: Introduces the definition of Nasopharyngeal Cancer, market overview.
Chapter 2: Global Nasopharyngeal Cancer market size in revenue.
Chapter 3: Detailed analysis of Nasopharyngeal Cancer company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Nasopharyngeal Cancer in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Nasopharyngeal Cancer Market, Global Outlook and Forecast 2023-2035 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
66 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Nasopharyngeal Cancer Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Nasopharyngeal Cancer Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Nasopharyngeal Cancer Overall Market Size
2.1 Global Nasopharyngeal Cancer Market Size: 2022 VS 2035
2.2 Global Nasopharyngeal Cancer Market Size, Prospects & Forecasts: 2018-2035
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Nasopharyngeal Cancer Players in Global Market
3.2 Top Global Nasopharyngeal Cancer Companies Ranked by Revenue
3.3 Global Nasopharyngeal Cancer Revenue by Companies
3.4 Top 3 and Top 5 Nasopharyngeal Cancer Companies in Global Market, by Revenue in 2022
3.5 Global Companies Nasopharyngeal Cancer Product Type
3.6 Tier 1, Tier 2 and Tier 3 Nasopharyngeal Cancer Players in Global Market
3.6.1 List of Global Tier 1 Nasopharyngeal Cancer Companies
3.6.2 List of Global Tier 2 and Tier 3 Nasopharyngeal Cancer Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Nasopharyngeal Cancer Market Size Markets, 2022 & 2035
4.1.2 Surgery
4.1.3 Radiation
4.1.4 Chemotherapy
4.2 By Type - Global Nasopharyngeal Cancer Revenue & Forecasts
4.2.1 By Type - Global Nasopharyngeal Cancer Revenue, 2018-2023
4.2.2 By Type - Global Nasopharyngeal Cancer Revenue, 2024-2035
4.2.3 By Type - Global Nasopharyngeal Cancer Revenue Market Share, 2018-2035
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Nasopharyngeal Cancer Market Size, 2022 & 2035
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Cancer Treatment and Rehabilitation Centers
5.2 By Application - Global Nasopharyngeal Cancer Revenue & Forecasts
5.2.1 By Application - Global Nasopharyngeal Cancer Revenue, 2018-2023
5.2.2 By Application - Global Nasopharyngeal Cancer Revenue, 2024-2035
5.2.3 By Application - Global Nasopharyngeal Cancer Revenue Market Share, 2018-2035
6 Sights by Region
6.1 By Region - Global Nasopharyngeal Cancer Market Size, 2022 & 2035
6.2 By Region - Global Nasopharyngeal Cancer Revenue & Forecasts
6.2.1 By Region - Global Nasopharyngeal Cancer Revenue, 2018-2023
6.2.2 By Region - Global Nasopharyngeal Cancer Revenue, 2024-2035
6.2.3 By Region - Global Nasopharyngeal Cancer Revenue Market Share, 2018-2035
6.3 North America
6.3.1 By Country - North America Nasopharyngeal Cancer Revenue, 2018-2035
6.3.2 US Nasopharyngeal Cancer Market Size, 2018-2035
6.3.3 Canada Nasopharyngeal Cancer Market Size, 2018-2035
6.3.4 Mexico Nasopharyngeal Cancer Market Size, 2018-2035
6.4 Europe
6.4.1 By Country - Europe Nasopharyngeal Cancer Revenue, 2018-2035
6.4.2 Germany Nasopharyngeal Cancer Market Size, 2018-2035
6.4.3 France Nasopharyngeal Cancer Market Size, 2018-2035
6.4.4 U.K. Nasopharyngeal Cancer Market Size, 2018-2035
6.4.5 Italy Nasopharyngeal Cancer Market Size, 2018-2035
6.4.6 Russia Nasopharyngeal Cancer Market Size, 2018-2035
6.4.7 Nordic Countries Nasopharyngeal Cancer Market Size, 2018-2035
6.4.8 Benelux Nasopharyngeal Cancer Market Size, 2018-2035
6.5 Asia
6.5.1 By Region - Asia Nasopharyngeal Cancer Revenue, 2018-2035
6.5.2 China Nasopharyngeal Cancer Market Size, 2018-2035
6.5.3 Japan Nasopharyngeal Cancer Market Size, 2018-2035
6.5.4 South Korea Nasopharyngeal Cancer Market Size, 2018-2035
6.5.5 Southeast Asia Nasopharyngeal Cancer Market Size, 2018-2035
6.5.6 India Nasopharyngeal Cancer Market Size, 2018-2035
6.6 South America
6.6.1 By Country - South America Nasopharyngeal Cancer Revenue, 2018-2035
6.6.2 Brazil Nasopharyngeal Cancer Market Size, 2018-2035
6.6.3 Argentina Nasopharyngeal Cancer Market Size, 2018-2035
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Nasopharyngeal Cancer Revenue, 2018-2035
6.7.2 Turkey Nasopharyngeal Cancer Market Size, 2018-2035
6.7.3 Israel Nasopharyngeal Cancer Market Size, 2018-2035
6.7.4 Saudi Arabia Nasopharyngeal Cancer Market Size, 2018-2035
6.7.5 UAE Nasopharyngeal Cancer Market Size, 2018-2035
7 Nasopharyngeal Cancer Companies Profiles
7.1 Roche
7.1.1 Roche Company Summary
7.1.2 Roche Business Overview
7.1.3 Roche Nasopharyngeal Cancer Major Product Offerings
7.1.4 Roche Nasopharyngeal Cancer Revenue in Global Market (2018-2023)
7.1.5 Roche Key News & Latest Developments
7.2 Sanofi
7.2.1 Sanofi Company Summary
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Nasopharyngeal Cancer Major Product Offerings
7.2.4 Sanofi Nasopharyngeal Cancer Revenue in Global Market (2018-2023)
7.2.5 Sanofi Key News & Latest Developments
7.3 Merck
7.3.1 Merck Company Summary
7.3.2 Merck Business Overview
7.3.3 Merck Nasopharyngeal Cancer Major Product Offerings
7.3.4 Merck Nasopharyngeal Cancer Revenue in Global Market (2018-2023)
7.3.5 Merck Key News & Latest Developments
7.4 Cyclacel Pharmaceuticals
7.4.1 Cyclacel Pharmaceuticals Company Summary
7.4.2 Cyclacel Pharmaceuticals Business Overview
7.4.3 Cyclacel Pharmaceuticals Nasopharyngeal Cancer Major Product Offerings
7.4.4 Cyclacel Pharmaceuticals Nasopharyngeal Cancer Revenue in Global Market (2018-2023)
7.4.5 Cyclacel Pharmaceuticals Key News & Latest Developments
7.5 Celgene
7.5.1 Celgene Company Summary
7.5.2 Celgene Business Overview
7.5.3 Celgene Nasopharyngeal Cancer Major Product Offerings
7.5.4 Celgene Nasopharyngeal Cancer Revenue in Global Market (2018-2023)
7.5.5 Celgene Key News & Latest Developments
7.6 BioDiem
7.6.1 BioDiem Company Summary
7.6.2 BioDiem Business Overview
7.6.3 BioDiem Nasopharyngeal Cancer Major Product Offerings
7.6.4 BioDiem Nasopharyngeal Cancer Revenue in Global Market (2018-2023)
7.6.5 BioDiem Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Nasopharyngeal Cancer Market Opportunities & Trends in Global Market
Table 2. Nasopharyngeal Cancer Market Drivers in Global Market
Table 3. Nasopharyngeal Cancer Market Restraints in Global Market
Table 4. Key Players of Nasopharyngeal Cancer in Global Market
Table 5. Top Nasopharyngeal Cancer Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Nasopharyngeal Cancer Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Nasopharyngeal Cancer Revenue Share by Companies, 2018-2023
Table 8. Global Companies Nasopharyngeal Cancer Product Type
Table 9. List of Global Tier 1 Nasopharyngeal Cancer Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Nasopharyngeal Cancer Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Nasopharyngeal Cancer Revenue, (US$, Mn), 2022 & 2035
Table 12. By Type - Nasopharyngeal Cancer Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Nasopharyngeal Cancer Revenue in Global (US$, Mn), 2024-2035
Table 14. By Application ? Global Nasopharyngeal Cancer Revenue, (US$, Mn), 2022 & 2035
Table 15. By Application - Nasopharyngeal Cancer Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Nasopharyngeal Cancer Revenue in Global (US$, Mn), 2024-2035
Table 17. By Region ? Global Nasopharyngeal Cancer Revenue, (US$, Mn), 2022 & 2035
Table 18. By Region - Global Nasopharyngeal Cancer Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Nasopharyngeal Cancer Revenue (US$, Mn), 2024-2035
Table 20. By Country - North America Nasopharyngeal Cancer Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Nasopharyngeal Cancer Revenue, (US$, Mn), 2024-2035
Table 22. By Country - Europe Nasopharyngeal Cancer Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Nasopharyngeal Cancer Revenue, (US$, Mn), 2024-2035
Table 24. By Region - Asia Nasopharyngeal Cancer Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Nasopharyngeal Cancer Revenue, (US$, Mn), 2024-2035
Table 26. By Country - South America Nasopharyngeal Cancer Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Nasopharyngeal Cancer Revenue, (US$, Mn), 2024-2035
Table 28. By Country - Middle East & Africa Nasopharyngeal Cancer Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Nasopharyngeal Cancer Revenue, (US$, Mn), 2024-2035
Table 30. Roche Company Summary
Table 31. Roche Nasopharyngeal Cancer Product Offerings
Table 32. Roche Nasopharyngeal Cancer Revenue (US$, Mn) & (2018-2023)
Table 33. Roche Key News & Latest Developments
Table 34. Sanofi Company Summary
Table 35. Sanofi Nasopharyngeal Cancer Product Offerings
Table 36. Sanofi Nasopharyngeal Cancer Revenue (US$, Mn) & (2018-2023)
Table 37. Sanofi Key News & Latest Developments
Table 38. Merck Company Summary
Table 39. Merck Nasopharyngeal Cancer Product Offerings
Table 40. Merck Nasopharyngeal Cancer Revenue (US$, Mn) & (2018-2023)
Table 41. Merck Key News & Latest Developments
Table 42. Cyclacel Pharmaceuticals Company Summary
Table 43. Cyclacel Pharmaceuticals Nasopharyngeal Cancer Product Offerings
Table 44. Cyclacel Pharmaceuticals Nasopharyngeal Cancer Revenue (US$, Mn) & (2018-2023)
Table 45. Cyclacel Pharmaceuticals Key News & Latest Developments
Table 46. Celgene Company Summary
Table 47. Celgene Nasopharyngeal Cancer Product Offerings
Table 48. Celgene Nasopharyngeal Cancer Revenue (US$, Mn) & (2018-2023)
Table 49. Celgene Key News & Latest Developments
Table 50. BioDiem Company Summary
Table 51. BioDiem Nasopharyngeal Cancer Product Offerings
Table 52. BioDiem Nasopharyngeal Cancer Revenue (US$, Mn) & (2018-2023)
Table 53. BioDiem Key News & Latest Developments
List of Figures
Figure 1. Nasopharyngeal Cancer Segment by Type in 2022
Figure 2. Nasopharyngeal Cancer Segment by Application in 2022
Figure 3. Global Nasopharyngeal Cancer Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Nasopharyngeal Cancer Market Size: 2022 VS 2035 (US$, Mn)
Figure 6. Global Nasopharyngeal Cancer Revenue, 2018-2035 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Nasopharyngeal Cancer Revenue in 2022
Figure 8. By Type - Global Nasopharyngeal Cancer Revenue Market Share, 2018-2035
Figure 9. By Application - Global Nasopharyngeal Cancer Revenue Market Share, 2018-2035
Figure 10. By Type - Global Nasopharyngeal Cancer Revenue, (US$, Mn), 2022 & 2035
Figure 11. By Type - Global Nasopharyngeal Cancer Revenue Market Share, 2018-2035
Figure 12. By Application - Global Nasopharyngeal Cancer Revenue, (US$, Mn), 2022 & 2035
Figure 13. By Application - Global Nasopharyngeal Cancer Revenue Market Share, 2018-2035
Figure 14. By Region - Global Nasopharyngeal Cancer Revenue Market Share, 2018-2035
Figure 15. By Country - North America Nasopharyngeal Cancer Revenue Market Share, 2018-2035
Figure 16. US Nasopharyngeal Cancer Revenue, (US$, Mn), 2018-2035
Figure 17. Canada Nasopharyngeal Cancer Revenue, (US$, Mn), 2018-2035
Figure 18. Mexico Nasopharyngeal Cancer Revenue, (US$, Mn), 2018-2035
Figure 19. By Country - Europe Nasopharyngeal Cancer Revenue Market Share, 2018-2035
Figure 20. Germany Nasopharyngeal Cancer Revenue, (US$, Mn), 2018-2035
Figure 21. France Nasopharyngeal Cancer Revenue, (US$, Mn), 2018-2035
Figure 22. U.K. Nasopharyngeal Cancer Revenue, (US$, Mn), 2018-2035
Figure 23. Italy Nasopharyngeal Cancer Revenue, (US$, Mn), 2018-2035
Figure 24. Russia Nasopharyngeal Cancer Revenue, (US$, Mn), 2018-2035
Figure 25. Nordic Countries Nasopharyngeal Cancer Revenue, (US$, Mn), 2018-2035
Figure 26. Benelux Nasopharyngeal Cancer Revenue, (US$, Mn), 2018-2035
Figure 27. By Region - Asia Nasopharyngeal Cancer Revenue Market Share, 2018-2035
Figure 28. China Nasopharyngeal Cancer Revenue, (US$, Mn), 2018-2035
Figure 29. Japan Nasopharyngeal Cancer Revenue, (US$, Mn), 2018-2035
Figure 30. South Korea Nasopharyngeal Cancer Revenue, (US$, Mn), 2018-2035
Figure 31. Southeast Asia Nasopharyngeal Cancer Revenue, (US$, Mn), 2018-2035
Figure 32. India Nasopharyngeal Cancer Revenue, (US$, Mn), 2018-2035
Figure 33. By Country - South America Nasopharyngeal Cancer Revenue Market Share, 2018-2035
Figure 34. Brazil Nasopharyngeal Cancer Revenue, (US$, Mn), 2018-2035
Figure 35. Argentina Nasopharyngeal Cancer Revenue, (US$, Mn), 2018-2035
Figure 36. By Country - Middle East & Africa Nasopharyngeal Cancer Revenue Market Share, 2018-2035
Figure 37. Turkey Nasopharyngeal Cancer Revenue, (US$, Mn), 2018-2035
Figure 38. Israel Nasopharyngeal Cancer Revenue, (US$, Mn), 2018-2035
Figure 39. Saudi Arabia Nasopharyngeal Cancer Revenue, (US$, Mn), 2018-2035
Figure 40. UAE Nasopharyngeal Cancer Revenue, (US$, Mn), 2018-2035
Figure 41. Roche Nasopharyngeal Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Sanofi Nasopharyngeal Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Merck Nasopharyngeal Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Cyclacel Pharmaceuticals Nasopharyngeal Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Celgene Nasopharyngeal Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. BioDiem Nasopharyngeal Cancer Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
